As we stand in 2025, we're witnessing a remarkable transformation in how we treat inflammatory bowel disease (IBD).
Thank you for all your efforts in supporting progress in this disease. It is hugely appreciated.
It looks like healthcare is on the same page worldwide treating IBD. Cost is still the obstacle to equitable access to advanced drug therapy.
Thank you for all your efforts in supporting progress in this disease. It is hugely appreciated.
It looks like healthcare is on the same page worldwide treating IBD. Cost is still the obstacle to equitable access to advanced drug therapy.